Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Vazquez

Showing results (91-100 of 172) with videos related to

Pageof 18
Sort By:
Cell Cycle (Georgetown, Tex.)|July 20, 2012
Metformin is synthetically lethal with glucose withdrawal in cancer cellsJavier A Menendez, Cristina Oliveras-Ferraros, Sílvia Cufí, et al.
Oncotarget|January 12, 2013
Autophagy-related gene 12 (ATG12) is a novel determinant of primary resistance to HER2-targeted therapies: utility of transcriptome analysis of the autophagy interactome to guide breast cancer treatmentSílvia Cufí, Alejandro Vazquez-Martin, Cristina Oliveras-Ferraros, et al.
International Journal of Oncology|November 21, 2008
Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: new prospects in the treatment of triple-negative/basal-like breast cancerCristina Oliveras-Ferraros, Alejandro Vazquez-Martin, Eugeni López-Bonet, et al.
Breast Cancer Research : BCR|February 26, 2011
Circulating fatty acid synthase: an exploratory biomarker to predict efficacy of the dual HER1/HER2 tyrosine kinase inhibitor lapatinibCristina Oliveras-Ferraros, Sílvia Cufí, Tamara Sauri-Nadal, et al.
Genes, Chromosomes & Cancer|February 15, 2011
Expression status of the autophagy-regulatory gene ATG6/BECN1 in ERBB2-positive breast carcinomas: bypassing ERBB2-induced oncogenic senescence to regulate the efficacy of ERBB2-targeted therapiesAlejandro Vazquez-Martin, Silvia Cufí, Cristina Oliveras-Ferraros, et al.
Oncology Reports|November 27, 2010
The anti-diabetic drug metformin suppresses the metastasis-associated protein CD24 in MDA-MB-468 triple-negative breast cancer cellsAlejandro Vazquez-Martin, Cristina Oliveras-Ferraros, Silvia Cufí, et al.
Scientific Reports|December 14, 2012
Metformin limits the tumourigenicity of iPS cells without affecting their pluripotencyAlejandro Vazquez-Martin, Sílvia Cufi, Eugeni Lopez-Bonet, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|May 24, 2011
Repositioning chloroquine and metformin to eliminate cancer stem cell traits in pre-malignant lesionsAlejandro Vazquez-Martin, Eugeni López-Bonetc, Sílvia Cufí, et al.
International Journal of Molecular Medicine|September 25, 2008
Analyzing effects of extra-virgin olive oil polyphenols on breast cancer-associated fatty acid synthase protein expression using reverse-phase protein microarraysJavier A Menendez, Alejandro Vazquez-Martin, Cristina Oliveras-Ferraros, et al.
Vaccine|November 12, 2018
Immunogenicity and safety of the 4CMenB and MenACWY-CRM meningococcal vaccines administered concomitantly in infants: A phase 3b, randomized controlled trialMercedes Macias Parra, Angela Gentile, Jorge Alejandro Vazquez Narvaez, et al.
Pageof 18

Showing results (91-100 of 172) with videos related to

Sort By:
Pageof 18
Cell Cycle (Georgetown, Tex.)|July 20, 2012
Metformin is synthetically lethal with glucose withdrawal in cancer cellsJavier A Menendez, Cristina Oliveras-Ferraros, Sílvia Cufí, et al.
Oncotarget|January 12, 2013
Autophagy-related gene 12 (ATG12) is a novel determinant of primary resistance to HER2-targeted therapies: utility of transcriptome analysis of the autophagy interactome to guide breast cancer treatmentSílvia Cufí, Alejandro Vazquez-Martin, Cristina Oliveras-Ferraros, et al.
International Journal of Oncology|November 21, 2008
Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: new prospects in the treatment of triple-negative/basal-like breast cancerCristina Oliveras-Ferraros, Alejandro Vazquez-Martin, Eugeni López-Bonet, et al.
Breast Cancer Research : BCR|February 26, 2011
Circulating fatty acid synthase: an exploratory biomarker to predict efficacy of the dual HER1/HER2 tyrosine kinase inhibitor lapatinibCristina Oliveras-Ferraros, Sílvia Cufí, Tamara Sauri-Nadal, et al.
Genes, Chromosomes & Cancer|February 15, 2011
Expression status of the autophagy-regulatory gene ATG6/BECN1 in ERBB2-positive breast carcinomas: bypassing ERBB2-induced oncogenic senescence to regulate the efficacy of ERBB2-targeted therapiesAlejandro Vazquez-Martin, Silvia Cufí, Cristina Oliveras-Ferraros, et al.
Oncology Reports|November 27, 2010
The anti-diabetic drug metformin suppresses the metastasis-associated protein CD24 in MDA-MB-468 triple-negative breast cancer cellsAlejandro Vazquez-Martin, Cristina Oliveras-Ferraros, Silvia Cufí, et al.
Scientific Reports|December 14, 2012
Metformin limits the tumourigenicity of iPS cells without affecting their pluripotencyAlejandro Vazquez-Martin, Sílvia Cufi, Eugeni Lopez-Bonet, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|May 24, 2011
Repositioning chloroquine and metformin to eliminate cancer stem cell traits in pre-malignant lesionsAlejandro Vazquez-Martin, Eugeni López-Bonetc, Sílvia Cufí, et al.
International Journal of Molecular Medicine|September 25, 2008
Analyzing effects of extra-virgin olive oil polyphenols on breast cancer-associated fatty acid synthase protein expression using reverse-phase protein microarraysJavier A Menendez, Alejandro Vazquez-Martin, Cristina Oliveras-Ferraros, et al.
Vaccine|November 12, 2018
Immunogenicity and safety of the 4CMenB and MenACWY-CRM meningococcal vaccines administered concomitantly in infants: A phase 3b, randomized controlled trialMercedes Macias Parra, Angela Gentile, Jorge Alejandro Vazquez Narvaez, et al.
Pageof 18